6402 Federal Register / Vol. 75, No. 26 / Tuesday, February 9, 2010 / Notices 

II. Electronic Access 

Persons with access to the Internet 

may obtain the documents at http:// 

www.fda.gov/BiologicsBloodVaccines/ 

BloodBloodProducts/Approved

Products/PremarketApprovalsPMAs/ 

ucm185249.htm 

Dated: February 4, 2010. 

Leslie Kux, 

Acting Assistant Commissioner for Policy. 

[FR Doc. 2010–2757 Filed 2–8–10; 8:45 am] 

BILLING CODE 4160–01–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Board of Scientific Counselors, 

National Center for Health Marketing 

(BSC, NCHM) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), and pursuant to the 

requirements of 42 CFR 83.15(a), the 

Centers for Disease Control and 

Prevention (CDC), announces the 

following meeting of the 

aforementioned committee: 

Times and Dates: 

9 a.m.–5 p.m., February 25, 2010. 

8:30 a.m.–1 p.m., February 26, 2010. 

Place: CDC, 2400 Century Parkway, 

Building 2400, Room 1A (1023), Atlanta, 

Georgia 30345. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 60 people. The 

toll free dial-in number is 1 (877) 617–5977 

with a pass code of 3468113. 

Purpose: The Secretary, Department of 

Health and Human Services (HHS), and, by 

delegation, the Director, CDC, are authorized 

under Section 301 (42 U.S.C. 241) and 

Section 311 (42 U.S.C. 243) of the Public 

Health Service Act (PHSA), as amended to: 

Develop and implement disease prevention 

and control, environmental health, and 

health promotion and health education 

activities designed to improve the health of 

the people of the United States. Under these 

and additional PHSA and other authorities, 

CDC acts by identifying and defining 

preventable health problems, maintaining 

active surveillance of diseases through 

epidemiologic and laboratory investigations 

and data collection, analysis, and 

distribution; conducting operational research 

aimed at developing and testing effective 

disease prevention, control, and health 

promotion programs; administering a 

national occupational safety and health 

program; controlling the introduction and 

spread of infectious diseases, and providing 

consultation and assistance to other nations 

and international agencies to assist in 

improving their disease prevention and 

control, environmental health, and health 

promotion activities. CDC carries out these 

functions through a number of National 

Centers, Institutes and Offices with expertise 

and responsibilities in specific areas. 

Matters To Be Discussed: The agenda will 

include: A discussion of the recent 

organizational changes at CDC, specifically 

presentations on the vision, mission, goals 

and organizational structure of the new 

Office of Communications; discussions on 

program activities, including scientific 

programs, that will enable the board to 

provide recommendations and advice on the 

future course for health communications and 

marketing at CDC; and a discussion of focus 

areas and new ideas to implement and 

expand health marketing science at CDC. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Dionne R. Mason, Committee Management 

Specialist, NCHM, CDC, 1600 Clifton Road, 

NE., Mail Stop E–21, Atlanta, Georgia 30333; 

Telephone: (404) 498–2314, Fax (404) 498– 

2221; E-mail: zsu0@cdc.gov. The deadline for 

notification of attendance is February 17, 

2010. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 1, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–2766 Filed 2–8–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Advisory Council for the Elimination of 

Tuberculosis (ACET) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC), 

announces the following meeting of the 

aforementioned committee: 

Times and Dates: 8:30 a.m.–5:30 p.m., 

March 2, 2010. 8:30 a.m.–2:30 p.m., March 3, 

2010. 

Place: CDC, Corporate Square, Building 8, 

1st Floor Conference Room, Atlanta, Georgia 

30333, telephone (404) 639–8317. 

Status: Open to the public, limited only by 

the space available. The meeting room 

accommodates approximately 100 people. 

Purpose: This council advises and makes 

recommendations to the Secretary of Health 

and Human Services, the Assistant Secretary 

for Health, and the Director, CDC, regarding 

the elimination of tuberculosis. Specifically, 

the Council makes recommendations 

regarding policies, strategies, objectives, and 

priorities; addresses the development and 

application of new technologies; and reviews 

the extent to which progress has been made 

toward eliminating tuberculosis. 

Matters To Be Discussed: Agenda items 

include issues pertaining to regionalization 

of tuberculosis care; the role of genetics in 

tuberculosis; tuberculosis control updates 

from the U.S. affiliated Pacific Islands; 

tuberculosis research updates; and other 

related tuberculosis issues. 

Agenda items are subject to change as 

priorities dictate. 

For More Information Contact: Margie 

Scott-Cseh, CDC, 1600 Clifton Road, NE., 

Mail Stop E–07, Atlanta, Georgia 30333, 

telephone (404) 639–8317. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register Notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both CDC and the Agency for Toxic 

Substances and Disease Registry. 

Dated: February 1, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–2768 Filed 2–8–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Fogarty International Center; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the Fogarty 

International Center Advisory Board. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications 

and/or contract proposals and the 

discussions could disclose confidential 

trade secrets or commercial property 

such as patentable material, and 

personal information concerning 

individuals associated with the grant 

applications and/or contract proposals, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Fogarty International 

Center Advisory Board. 


Cprice-sewell on DSK2BSOYB1PROD with NOTICES
Federal Register / Vol. 75, No. 26 / Tuesday, February 9, 2010 / Notices 6403 

Date: February 9, 2010. 

Closed: 8:30 a.m. to 12 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: National Institutes of Health, 

Lawton Chiles International House, Bethesda, 

MD 20892. 

Open: 12 p.m. to 3:30 p.m. 

Agenda: A report of the FIC Director on 

updates and overviews of new FIC initiatives. 

Topics to be discussed: New Developments 

in Chronic Disease Research and Training. 

Place: National Institutes of Health, 

Lawton Chiles International House, Bethesda, 

MD 20892. 

Contact Person: Robert Eiss, Public Health 

Advisor, Fogarty International Center, 

National Institutes of Health, 31 Center Drive, 

Room B2C02, Bethesda, MD 20892.(301) 

496–1415. eissr@mail.nih.gov. 

This meeting is being published less than 

15 days prior to the meeting due to timing 

limitations imposed by administrative 

matters. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, drivers license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institutes/Center’s home page: http:// 

www.nih.gov/fic/about/advisory.html, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.106, Minority International 

Research Training Grant in the Biomedical 

and Behavioral Sciences; 93.154, Special 

International Postdoctoral Research Program 

in Acquired Immunodeficiency Syndrome; 

93.168, International Cooperative 

Biodiversity Groups Program; 93.934, Fogarty 

International Research Collaboration Award; 

93.989, Senior International Fellowship 

Awards Program, National Institutes of 

Health, HHS) 

Dated: February 1, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–2559 Filed 2–8–10; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

National Center for Health Statistics 

(NCHS), Classifications and Public 

Health Data Standards Staff, 

announces the following meeting: 

Name: ICD–9–CM Coordination and 

Maintenance Committee meeting. 

Time and Date: 9 a.m.–4:30 p.m., 

March 9–10, 2010. 

Place: Centers for Medicare and 

Medicaid Services (CMS) Auditorium, 

7500 Security Boulevard, Baltimore, 

Maryland. 

Status: Open to the public. 

Purpose: The ICD–9–CM Coordination 

and Maintenance (C&M) Committee will 

hold its first meeting of the 2010 

calendar year cycle on Tuesday and 

Wednesday March 9–10, 2010. The 

C&M meeting is a public forum for the 

presentation of proposed modifications 

to the International Classification of 

Diseases, Ninth-Revision, Clinical 

Modification. 

Matters to be Discussed: Tentative 

agenda items include: 

March 9, 2010: 

ICD–10 updates: GEMs; Freeze 

update; ICD–10–CM/ICD–10–PCS 

updates 

Application of Collagen Based Tissue 

Sealant Patches 

Biopsy of Soft Tissue Mass 

Central Venous Catheter Placement 

Using Intra-Atrial 

Electrocardiographic Guidance 

Circulating Tumor Cell Enumeration, 

Magnetic 

Closed Chest Intra-cardiac Mitral 

Valve Repair 

Continuous Glucose Monitoring 

Fat Graft to Breast 

Insertion of Intracranial 

Neurostimulator Lead(s) 

Internal Fixation of Sternum 

Intralaminar Lumbar Decompression 

and Laminotomy with 

Epidurography 

Intra-operative Fluorescence Vascular 

Angiography (IFVA) 

Laparoscopic Hernia Repair without 

Mesh 

Thoracoscopic Cardiac Ablation 

Addenda (procedures) 

March 10, 2010: 

Acquired absence of joint 

Brain death 

Eaton-Lambert Syndrome 

E. coli infection 

Fluency disorders (stuttering) 

Glaucoma staging 

H1N1 (Swine flu) 

Transfusion transmitted infections 

Uranium exposure 

Addenda (diagnoses) 

Contact Person for Additional 

Information: Amy Blum, Medical 

Systems Specialist, Classifications and 

Public Health Data Standards Staff, 

NCHS, 3311 Toledo Road, Room 2402, 

Hyattsville, Maryland 20782, e-mail 

alb8@cdc.gov, telephone 301–458–4106 

(diagnosis), Mady Hue, Health 

Insurance Specialist, Division of Acute 

Care, CMS, 7500 Security Blvd., 

Baltimore, Maryland 21244, e-mail 

marilu.hue@cms.hhs.gov, telephone 

410–786–4510 (procedures). Note: CMS 

and NCHS will no longer be providing 

paper copies of handouts for the 

meeting. Electronic copies of all meeting 

materials will be posted on the CMS and 

NCHS Web sites prior to the meeting at 

http://www.cms.hhs.gov/ 

ICD9ProviderDiagnosticCodes/ 

03_meetings.asp#TopOfPage and http:// 

www.cdc.gov/nchs/icd/ 

icd9cm_maintenance.htm. 

Notice: Because of increased security 

requirements CMS has instituted 

stringent procedures for entrance into 

the building by non-government 

employees. Persons without a 

government I.D. will need to show an 

official form of picture I.D., (such as a 

drivers license), and sign-in at the 

security desk upon entering the 

building. 

Those who wish to attend a specific 

ICD–9–CM C&M meeting in the CMS 

auditorium must submit their name and 

organization for addition to the meeting 

visitor list. Those wishing to attend the 

March 9–10, 2010 meeting must submit 

their name and organization by March 5, 

2010 for inclusion on the visitor list. 

This visitor list will be maintained at 

the front desk of the CMS building and 

used by the guards to admit visitors to 

the meeting. Those who attended 

previous ICD–9–CM C&M meetings will 

no longer be automatically added to the 

visitor list. You must request inclusion 

of your name prior to each meeting you 

attend. Register to attend the meeting 

on-line at: http://www.cms.hhs.gov/ 

apps/events/. 

Notice: This is a public meeting. 

However, because of fire code 

requirements, should the number of 

attendants meet the capacity of the 

room, the meeting will be closed. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 


Cprice-sewell on DSK2BSOYB1PROD with NOTICES